- Drug Pipelines
- February 2019
- 43 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €19817EUR$22,000USD£17,120GBP
- Report
- December 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- November 2018
- 53 Pages
Global
From €7652EUR$8,495USD£6,611GBP
- Report
- November 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- November 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- November 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- November 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- October 2018
- 50 Pages
Global
From €3148EUR$3,495USD£2,720GBP
- Report
- October 2018
- 16 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Report
- October 2018
- 106 Pages
Global
From €2252EUR$2,500USD£1,945GBP
- Report
- October 2018
- 19 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Report
- October 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- September 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- August 2018
- 21 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Report
- July 2018
- 27 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Report
- July 2018
- 33 Pages
Global
From €9008EUR$10,000USD£7,782GBP
- Report
- July 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- July 2018
- 30 Pages
China
From €1982EUR$2,200USD£1,712GBP
- Report
- July 2018
- 14 Pages
Global
From €9008EUR$10,000USD£7,782GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more